(Q51968408)

19 April 2018

title

Atypical depressive syndromes in varying definitions. (English)

1 reference

19 April 2018

author

Vladeta Ajdacic

5

1 reference

19 April 2018

Wulf Rössler

7

object named as

Wulf Rössler

1 reference

19 April 2018

1

Jules Angst

1 reference

19 April 2018

author name string

Alex Gamma

2

1 reference

19 April 2018

Franco Benazzi

3

1 reference

19 April 2018

Brett Silverstein

4

1 reference

19 April 2018

Dominique Eich

6

1 reference

19 April 2018

publication date

27 July 2005

1 reference

19 April 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

19 April 2018

volume

256

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

44-54

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1007/s00406-005-0600-z

exact match

0 references

cites work

Atypical depression: clinical aspects and noradrenergic function

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

The tyramine challenge test as a marker for melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Reversed neurovegetative symptoms of depression: a community study of Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

A multiple-dose, controlled study of phenelzine in depression-anxiety states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Latent class analysis of lifetime depressive symptoms in the national comorbidity survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Sleep EEG and DST findings in anergic bipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-005-0600-Z

Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes

21 January 2018

1 reference

12 December 2020

THE ANTIDEPRESSANT DRUGS.

1 reference

12 December 2020

Course and treatment of atypical depression.

1 reference

12 December 2020

Pattern-reversed visual evoked potentials in subtypes of major depression

1 reference

12 December 2020

Familiality of symptom dimensions in depression.

1 reference

12 December 2020

The nature of bipolar depression: implications for the definition of melancholia

1 reference

12 December 2020

Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms.

1 reference

12 December 2020

Forms of atypical depression and their response to antidepressant drugs.

1 reference

12 December 2020

Atypical depressive symptoms and clusters in unipolar and bipolar depression.

1 reference

12 December 2020

Sleep of atypical depressives.

1 reference

12 December 2020

Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.

1 reference

12 December 2020

Atypical depression. A valid clinical entity?

1 reference

12 December 2020

A Clinical Trial of Phenelzine in Anxiety Depressive and Phobic Neuroses

1 reference

12 December 2020

Atypical depression in private practice depressed outpatients: a 203-case study.

1 reference

12 December 2020

Testing DSM-IV definition of atypical depression

1 reference

12 December 2020

The high prevalence of "soft" bipolar (II) features in atypical depression

1 reference

12 December 2020

Bipolar II depression in late life: prevalence and clinical features in 525 depressed outpatients

1 reference

12 December 2020

Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences

1 reference

12 December 2020

Atypical depression: a reappraisal

1 reference

12 December 2020

Can only reversed vegetative symptoms define atypical depression?

1 reference

12 December 2020

The validity of major depression with atypical features based on a community study.

1 reference

12 December 2020

Late-life atypical major depressive episode: a 358-case study in outpatients

1 reference

12 December 2020

Pharmacotherapy response and diagnostic validity in atypical depression.

1 reference

12 December 2020

Biological and clinical validation of atypical depression.

1 reference

12 December 2020

Depression with DSM-IV atypical features: a marker for bipolar II disorder

1 reference

12 December 2020

Clinical significance of reversed vegetative subtypes of recurrent major depression

1 reference

12 December 2020

The prevalence of atypical features across mood, anxiety, and personality disorders

1 reference

12 December 2020

Toward validation of atypical depression in the community: results of the Zurich cohort study.

1 reference

12 December 2020

Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

1 reference

12 December 2020

Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.

1 reference

12 December 2020

Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission

1 reference

12 December 2020

Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces.

1 reference

12 December 2020

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design

1 reference

12 December 2020

Should mood reactivity be included in the DSM-IV atypical features specifier?

1 reference

12 December 2020

Effects of iproniazid in depressive syndromes.

1 reference

12 December 2020

The subtypes of major depression in a twin registry

1 reference

12 December 2020

Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol

1 reference

12 December 2020

Early-onset versus late-onset atypical depression: unipolar and bipolar II.

1 reference

12 December 2020

10.1007/S00406-005-0600-Z

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018